Review: taking Diphenhydramine hydrochloride and Gravol together


Summary

Drug interactions are reported among people who take Diphenhydramine hydrochloride and Gravol together. This review analyzes the effectiveness and drug interactions between Diphenhydramine hydrochloride and Gravol. It is created by eHealthMe based on reports of 163 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Diphenhydramine hydrochloride and Gravol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Diphenhydramine Hydrochloride

Diphenhydramine hydrochloride has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. (latest outcomes from Diphenhydramine hydrochloride 3,471 users)

Gravol

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. (latest outcomes from Gravol 917 users)

On Aug, 26, 2016

163 people who take Diphenhydramine Hydrochloride, Gravol are studied.


Number of reports submitted per year:

Diphenhydramine hydrochloride and Gravol drug interactions.

Drug effectiveness over time:

Diphenhydramine Hydrochloride:
  • < 1 month: 20.0% - (1 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Gravol:
  • < 1 month: 60.0% - (3 of 5 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Diphenhydramine Hydrochloride:
  • female: 33.0% - (2 of 6 people)
  • male: 40.0% - (2 of 5 people)
Gravol:
  • female: 66.0% - (4 of 6 people)
  • male: 66.0% - (4 of 6 people)

Drug effectiveness by age:

Diphenhydramine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 60.0% - (3 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)
Gravol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 80.0% - (4 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • kidney transplant rejection
  • atelectasis
  • cardiomegaly
  • convulsion
  • oxygen saturation decreased
  • pneumothorax
  • respiratory distress
  • anaemia
  • arteriospasm coronary
  • drowsiness
1 - 6 months:
  • drowsiness
  • nausea
  • vertigo
6 - 12 months:
  • erectile dysfunction
  • sleep disorder due to general medical condition, insomnia type
1 - 2 years:
  • acute myeloid leukaemia
  • cardiac failure congestive
  • disease progression
  • ejection fraction decreased
  • lethargy
  • mucosal inflammation
  • oedema
2 - 5 years:
  • pulmonary mycosis
  • arthralgia
  • chronic graft versus host disease
  • diarrhoea
  • drug ineffective
  • joint swelling
  • pain
5 - 10 years:
  • demerol overdose
  • erectile dysfunction
  • sleep disorder due to general medical condition, insomnia type
10+ years:
  • demerol overdose
not specified:
  • infusion related reaction
  • vomiting
  • nausea
  • fatigue
  • dizziness
  • weight decreased
  • pyrexia
  • depressed level of consciousness
  • febrile neutropenia
  • cerebrovascular accident

Most common drug interactions by gender *:

female:
  • infusion related reaction
  • nausea
  • dyspnoea
  • febrile neutropenia
  • chest discomfort
  • vomiting
  • hypotension
  • drug ineffective
  • pleural effusion
  • pruritus
male:
  • vomiting
  • dizziness
  • fatigue
  • weight decreased
  • cerebrovascular accident
  • diabetic coma
  • pyrexia
  • hypoglycaemia
  • nausea
  • convulsion

Most common drug interactions by age *:

0-1:
  • brain death
  • dyspnoea
  • hyponatraemia
  • inappropriate adh secretion
2-9:
  • aphasia
  • depressed level of consciousness
  • excessive eye blinking
  • neurotoxicity
  • staring
  • unresponsive to stimuli
  • urinary incontinence
10-19:
  • depressed level of consciousness
  • disseminated intravascular coagulation
  • febrile neutropenia
  • fluid overload
  • general physical health deterioration
  • haematemesis
  • hepatitis
  • hypertension
  • hypokalaemia
  • hypomagnesaemia
20-29:
  • dizziness
  • platelet count decreased
  • chest discomfort
  • completed suicide
  • fatigue
  • haemoglobin decreased
  • infusion related reaction
  • vomiting
  • abdominal pain
  • abdominal pain upper
30-39:
  • oxygen saturation decreased
  • atelectasis
  • cardiomegaly
  • convulsion
  • infusion related reaction
  • pneumothorax
  • respiratory distress
  • vomiting
  • chest discomfort
  • dyspnoea
40-49:
  • blood lactate dehydrogenase increased
  • engraftment syndrome
  • febrile neutropenia
  • lung infiltration
  • pericardial effusion
  • pleural effusion
  • convulsion
  • dysphagia
  • infection
  • infusion related reaction
50-59:
  • infusion related reaction
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood creatinine increased
  • nausea
  • febrile neutropenia
  • blood pressure decreased
  • chest pain
  • feeling cold
60+:
  • depressed level of consciousness
  • fluid overload
  • cardiac arrest
  • myocardial infarction
  • blood creatinine increased
  • hypotension
  • neutropenia
  • oliguria
  • pleural effusion
  • rash

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Diphenhydramine hydrochloride and Gravol?

Can you answer these questions?

More questions for: Diphenhydramine hydrochloride, Gravol

You may be interested in these reviews

More reviews for: Diphenhydramine hydrochloride, Gravol

On eHealthMe, Diphenhydramine hydrochloride (diphenhydramine hydrochloride) is often used to treat insomnia. Gravol (dimenhydrinate) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.